• Carbenoxolone disodium: Practical Lab Guide

  2026-08-29

  Carbenoxolone disodium (SKU A8389) is a mechanistic research reagent for studying 11β-hydroxysteroid dehydrogenase activity, glucocorticoid access, and gap junction communication in cell- and tissue-based systems. It is appropriate for controlled pathway experiments, but not for interpreting in vivo efficacy or selective target effects when viability and off-target activity cannot be separated.

• TEAD2, Ferroptosis, and HCC Prognosis

  2026-08-28

  Ren et al. combined public cancer databases with in vitro validation to identify TEAD2 and TEAD4 as elevated in hepatocellular carcinoma, while linking TEAD2 expression to adverse survival and ferroptosis regulation. The study positions TEAD2 as a candidate prognostic and mechanistic target, although its clinical and therapeutic relevance requires validation in larger cohorts and in vivo models.

• PPM-18: A Redox-Aware iNOS Research Strategy

  2026-08-28

  PPM-18 is an NF-κB-linked iNOS expression inhibitor for dissecting inflammatory nitric oxide biology. This article connects its transcriptional mechanism with redox-sensitive cardiac signaling and provides assay-planning guidance for inflammation and sepsis research.

• X-Gal Workflows for Cloning and Assay Troubleshooting

  2026-08-27

  Use X-Gal to turn lacZα complementation into a rapid visual checkpoint for molecular cloning, then extend the same construct-validation logic to reporter and cell-based experiments. This guide combines practical screening conditions, assay-selection advice, and troubleshooting with insights from iRhom2 olfaction research.

• Brefeldin A: From Trafficking Block to ER Stress

  2026-08-27

  Brefeldin A is more than a vesicle transport inhibitor: it is a controlled way to connect ER–Golgi disruption with proteostasis, ER stress, and cancer-cell fate. This guide translates UBR1/UBR2 findings into practical assay decisions and interpretable BFA workflows.

• Tigecycline in the New Era of CREC Transmission

  2026-08-26

  Carbapenemase mobility is reshaping multidrug-resistance research. This thought-leadership guide positions Tigecycline as a mechanistically distinct translational tool for connecting CREC genomics, susceptibility testing, MRSA research, and infection-model design without overstating what genotype alone can predict.

• Solanesol B8776: Practical Research Workflow Guide

  2026-08-26

  Solanesol is a hydrophobic polyisoprenoid alcohol for controlled biochemical and pharmaceutical research workflows, including apoptosis research, DNA damage and repair studies, metabolic enzyme assays, and protease activity research. This guide addresses solvent selection, fresh-solution handling, precipitation control, and assay controls; the material is not suitable for water- or ethanol-only systems, diagnostic use, or medical applications.

• Cinoxacin: From MIC to Translational Assay Design

  2026-08-25

  Cinoxacin is a quinolone antibiotic with a defined Gram-negative activity profile and practical value in urinary tract infection research. This article develops an assay-design framework that connects MIC interpretation, exposure-aware experiments, resistance studies, and lessons from precision clinical-trial methodology.

• Erastin Workflows for Ferroptosis Research

  2026-08-25

  Erastin is a practical ferroptosis inducer for connecting RAS/BRAF genotype, cystine–glutathione depletion, oxidative stress, and tumor-cell viability. This workflow covers fresh-solution handling, orthogonal assay design, pancreatic cancer applications, and troubleshooting strategies that help distinguish ferroptosis from nonspecific cytotoxicity.

• α-Bungarotoxin for Nicotinic Receptor Blockade

  2026-08-24

  α-Bungarotoxin turns α7 nicotinic acetylcholine receptor involvement into a testable variable across neuronal, neuromuscular, and placental assays. This practical guide covers receptor-blockade design, concentration planning, pathway-level controls, and troubleshooting for cholinergic signaling and necroptosis studies.

• Rotavirus Infection Suppresses Nrf2 Redox Defense

  2026-08-24

  This study shows that rotavirus infection produces a biphasic Nrf2 response: an early, redox-sensitive increase is followed by progressive Nrf2 depletion, nuclear loss, and suppression of antioxidant gene expression. Its mechanistic analysis implicates proteasome-associated, K48-linked ubiquitination rather than canonical Keap1/Cul3-Rbx1 turnover as a major contributor to late Nrf2 loss, providing a framework for studying virus-induced disruption of cellular stress adaptation.

• Methoxy-X04 Maps Exercise-Driven Aβ Clearance

  2026-08-23

  Methoxy-X04 is a fluorescent amyloid beta probe for connecting plaque burden with microglial clearance mechanisms in Alzheimer’s disease models. This article develops an assay strategy inspired by exercise-induced skeletal muscle extracellular vesicles, emphasizing interpretation, controls, and biological meaning rather than routine imaging alone.

• Nullscript: Epigenetic Leverage for Translational Research

  2026-08-22

  Nullscript illustrates why HDAC inhibitor research should separate enzyme inhibition from downstream transcriptional behavior. This thought-leadership guide connects its mechanistic profile and cardioprotective preclinical signal with a disciplined validation strategy, while using recent necroptosis research to define—not overstate—opportunities for translational investigation.

• Temafloxacin Combinations Against M. avium

  2026-08-22

  This 1993 study evaluated clarithromycin, temafloxacin, and ethambutol against pigmented and non-pigmented Mycobacterium avium complex isolates using MIC, fractional inhibitory concentration, and macrophage models. Its central contribution was to show that combination activity was strain dependent in agar assays, while the three-drug combination produced the strongest intracellular bactericidal effect.

• JNJ-10198409 PDGF Receptor Assay Guide

  2026-08-21

  This scenario-based guide shows how JNJ-10198409, SKU C5737, can support reproducible PDGF-BB receptor inhibition studies across viability, proliferation, and cytotoxicity assays. It covers dose selection, solvent compatibility, protocol optimization, data interpretation, and practical vendor evaluation using the compound’s documented potency and formulation data.

8467 records 1/565 page Next 12345 下5页 Last page